Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Differential censoring in clinical trials can bias survival outcomes. Imbalanced censoring favoring the control arm often indicates a suboptimal control and may affect overall survival results.
Area Of Science
- Clinical Trials
- Biostatistics
- Oncology Research
Background
- Differential censoring, an imbalance in patient censoring between treatment groups, can compromise the integrity of survival outcome analyses in clinical trials.
- This phenomenon may lead to biased interpretations, particularly in oncology studies relying on time-to-event endpoints.
Purpose Of The Study
- To investigate the association between differential censoring in surrogate primary endpoints and the statistical significance of overall survival (OS) results in phase III oncology trials.
- To evaluate if differential censoring is linked to the adequacy of the control arm in these trials.
Main Methods
- Analysis of 146 phase III oncology trials with statistically significant time-to-event surrogate primary endpoints.
- Assessment of differential censoring favoring either the control or experimental arm.
- Correlation of censoring patterns with control arm adequacy and OS statistical significance.
Main Results
- Differential censoring was observed in 26% of trials (24% favoring control, 10% favoring experimental).
- Trials with control arm-favoring differential censoring showed a higher likelihood of statistically significant OS (63%) compared to non-differential censoring (37%) or experimental arm-favoring censoring (47%).
- Suboptimal control arms were more prevalent in trials with control arm-favoring differential censoring (46%) versus others (20-13%).
Conclusions
- Differential censoring, especially when favoring the control arm, is associated with statistically significant overall survival results in oncology trials.
- The presence of control arm-favoring differential censoring may signal an inadequate control arm and warrants careful examination and explanation.
- Findings highlight the importance of assessing censoring patterns for robust interpretation of survival data in clinical research.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...